Form D Explorer
TuHURA Biosciences, Inc./NV · CIK 1498382

Report a data issueCitable research briefCompare issuerPrivate research collection

TuHURA Biosciences, Inc./NV

CIK 1498382 · Corporation · Inc. NEVADA · TAMPA, Florida · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Jun 13, 2025
through Nov 10, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 13, 2025 · DNov 10, 2025 · DLater minus earlier
Reported offering amount$12,612,120$3,000,000$-9,612,120
Reported amount sold$2,228,043$1,500,000$-728,043
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0000950123-25-006026 · Later SEC source: 0001498382-25-000004

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Nov 10, 2025

Reported offering amount
$3,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,500,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)